| scholarly article | Q13442814 |
| P2093 | author name string | Ederveen AG | |
| Kloosterboer HJ | |||
| P2860 | cites work | Pharmacology of two new very selective antiprogestagens: Org 31710 and Org 31806. | Q54766179 |
| The design and use of sex-steroid antagonists | Q60530443 | ||
| Long-term estrogen replacement therapy prevents bone loss and fractures | Q70078558 | ||
| P433 | issue | 9 | |
| P304 | page(s) | 1651-1657 | |
| P577 | publication date | 2001-09-01 | |
| P1433 | published in | Journal of Bone and Mineral Research | Q15750941 |
| P1476 | title | Tibolone exerts its protective effect on trabecular bone loss through the estrogen receptor | |
| P478 | volume | 16 |
| Q35753441 | A review of the effects of tibolone on the skeleton |
| Q44429302 | Androgens and Women at the Menopause and Beyond |
| Q42487188 | Effect of prolonged use of high dose of tibolone on the vagina of ovariectomized rats |
| Q46767327 | Effects of tibolone and raloxifene on bone mineral density in osteopenic postmenopausal women |
| Q48586031 | Historical milestones in the development of tibolone (Livial®). |
| Q35089986 | Pros and cons of existing treatment modalities in osteoporosis: a comparison between tibolone, SERMs and estrogen (+/-progestogen) treatments. |
| Q44355123 | Ten years of treatment with tibolone 2.5 mg daily: effects on bone loss in postmenopausal women |
| Q36933363 | The effects of tibolone in older postmenopausal women |
| Q37768413 | Tibolone in postmenopausal women: a review based on recent randomised controlled clinical trials |
| Q35693770 | Tibolone: a unique version of hormone replacement therapy |
Search more.